Inari Medical (NARI.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Mar6

Inari Medical Launches Artix Thrombectomy System to Improve Outcomes for Arterial Thrombectomy Patients

18:38

Feb3

Halper Sadeh LLC Investigates Inari Medical, Inc. for Potential Violations of Securities Laws and Fiduciary Duties

19:02

Jan24

Kuehn Law Investigates Potential Claims Related to Mergers with Inari Medical and Others

15:02

Oct29

Inari Medical, Inc. announces positive results from the PEERLESS randomized controlled trial

16:01

Inari Medical released FY2024 9 Months Earnings on October 28 (EST), with actual revenue of 442.4 M USD and EPS of -1.2746 USD

03:00

Inari Medical released FY2024 Q3 earnings on October 28 (EST), actual revenue $153.39M (forecast $150.67M), actual EPS -$0.3146 (forecast -$0.1956)

03:00

Schedules & Filings

Schedules

Filings

Oct28

Earning Release(EST)

FY2024 Q3 Earning Release (USD) Revenue 153.39 M, Net Income -18.37 M, EPS -0.3146

Jul30

Earning Release(EST)

FY2024 Q2 Earning Release (USD) Revenue 145.82 M, Net Income -31.35 M, EPS -0.5399

Apr30

Earning Release(EST)

FY2024 Q1 Earning Release (USD) Revenue 143.19 M, Net Income -24.2 M, EPS -0.4199

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More